Spectracell Labs – https://www.spectracell.com
SpectraCell’s MicroNutrient Testing:
SpectraCell’s MicroNutrient Testing measures how micronutrients are actually functioning within your white blood cells. Unlike serum testing that measures the nutrients in serum and does not give an indication of availability in cellular tissue, white blood cell testing does, and is an indicator of nutritional biochemical availability.
SpectraCell’s Micronutrient Testing results allow insight into the nutritional factors that contribute to many clinical conditions including; arthritis, cancer, cardiovascular risk, diabetes, malabsorption of nutrients, and various immunological, metabolic or neurological disorders. The test can provide guidance to what nutrients are most needed for your body’s optimal functioning. Once this test is conducted, it is best to re-test in minimum 3 months and up to 9 months to see if nutritional changes adopted had efficacy.
SpectraCell’s CardioMetabolic Testing:
SpectraCell’s CardioMetabolic test offers a clinically relevant evaluation to help define risk for atherosclerotic cardiovascular disease (ASCVD), progression toward Type 2 Diabetes, and inflammation. It includes SpectraCell’s Advanced Lipoprotein Particle Profile™ Plus (LPPTM Plus), which measures lipoprotein size and density; cardiovascular risk stratification; and also includes triglycerides and traditional cholesterol screening. Each patient is assigned a CardioMetabolic Risk Assessment, which is an indication of your risk (Low, Moderate or High) for developing cardiovascular disease, including stroke and diabetes. In addition, the Type 2 Diabetes Risk Assessment is an estimate of your risk of developing Type 2 Diabetes. These check points help patients understand that not just one factor, but rather a constellation of risk factors, contribute to the genesis and progression toward poor blood sugar control and/or ASCVD. Results of testing allow clinicians to know when guidance, educational referral, or treatment is necessary. Key components of the CardioMetabolic Risk Panel are listed below
If you have one of the following below, you should take the CardioMetabolic Test or Pre-Diabetes Risk Panel.
- Have a family history of heart disease or diabetes
- Have been diagnosed with heart disease or diabetes
- Are already taking cholesterol-lowering medications
- Have been diagnosed with Metabolic Syndrome (high blood pressure)
- Are overweight
- Have high LDL – the bad cholesterol
- Have low HDL – the good cholesterol
- Have high triglycerides